AJ

Ajaykumar Jamnadas Sheth

Active Director Director DIN 01483574
DIN 01483574 First appointment Sep 2005 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Current companies 3 active board seats
Past companies 2 historical roles
Total affiliations 5 Since Sep 2005
Shareholding value •••• Premium profile

About Ajaykumar Jamnadas Sheth

Data last updated:

Ajaykumar Jamnadas Sheth is a Director at Aarsh Remedies Private Limited (since 2010), Director at A Square Remedies Private Limited (since 2011) and Director at Sugen Pharma Private Limited (since 2012). The companies operate in Pharma. The 3 current companies with reported revenue have a combined latest revenue of ₹28.89 Cr; the largest is Aarsh Remedies Private Limited at ₹17.64 Cr (FY 2025). Earlier, Ajaykumar Jamnadas Sheth was a Director at Shantam Pharmaceuticals Pvt Ltd (2011–2015) and Director at Ascent Remedies Private Limited (from 2005).

DIN 01483574
Primary Designation Director
Industry Pharma
First Appointment 09 Sep 2005
Oldest Company Age 21 yrs
Largest company Aarsh Remedies Private Limited · ₹17.64 Cr (FY 2025)
Combined revenue ₹28.89 Cr across 3 companies

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Aarsh Remedies Private Limited U24230GJ2010PTC059782
Director06 Mar 20102010₹17.64 Cr (FY 2025)Active
A Square Remedies Private Limited U24230GJ2011PTC063575
Director10 Jan 20112011₹9.06 Cr (FY 2025)Active
Sugen Pharma Private Limited U24230GJ2012PTC068756
Director25 Jan 20122012₹2.19 Cr (FY 2025)Active

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Shantam Pharmaceuticals Pvt Ltd U24230GJ1995PTC024121
Director01 Sep 20111995₹9.94 Cr (FY 2025)Active
Ascent Remedies Private Limited U24230GJ2005PTC046736
Director09 Sep 20052005Strike Off

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Ascent Remedies Private Limited
Aarsh Remedies Private Limited
A Square Remedies Private Limited
Sugen Pharma Private Limited
Premium access

Shareholding and investment profile for Ajaykumar Jamnadas Sheth

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Ajaykumar Jamnadas Sheth

Ajaykumar Jamnadas Sheth currently holds 3 directorships: Aarsh Remedies Private Limited (Director, since 06 Mar 2010, revenue ₹17.64 Cr (FY 2025)); A Square Remedies Private Limited (Director, since 10 Jan 2011, revenue ₹9.06 Cr (FY 2025)); Sugen Pharma Private Limited (Director, since 25 Jan 2012, revenue ₹2.19 Cr (FY 2025)).

Ajaykumar Jamnadas Sheth was first appointed on 09 Sep 2005 as Director at Ascent Remedies Private Limited. The most recent appointment on record is 25 Jan 2012 at Sugen Pharma Private Limited.

The 3 current companies of Ajaykumar Jamnadas Sheth that report revenue have a combined latest revenue of ₹28.89 Cr: Aarsh Remedies Private Limited ₹17.64 Cr (FY 2025); A Square Remedies Private Limited ₹9.06 Cr (FY 2025); Sugen Pharma Private Limited ₹2.19 Cr (FY 2025).

Ajaykumar Jamnadas Sheth held 2 earlier board appointments: Shantam Pharmaceuticals Pvt Ltd (Director, 01 Sep 2011 to 14 Jul 2015); Ascent Remedies Private Limited (Director, from 09 Sep 2005).

The current boards of Ajaykumar Jamnadas Sheth's companies include Anuradhaben Ajaybhai Sheth (Aarsh Remedies Private Limited), Birju Kiritkumar Shah (A Square Remedies Private Limited), Jigar Jaswantsinh Jadeja (A Square Remedies Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available